Method of treatment of diabetic nephropathy by means of sulodexi

Details Method of treatment of diabetic nephropathy by means of sulodexi Method of treatment of diabetic nephropathy by means of sulodexi

1994-04-14

1996-03-05

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 64, A61K 3170, A61K 3169

Patent

active

054968070

ABSTRACT:
The use of sulodexide, a glycosaminoglycan of natural origin extracted from mammalian intestinal mucosa, and of medicines containing it in the treatment of patients suffering from nephropathy of diabetic origin constitutes the object of the present invention. The effectiveness of sulodexide has been shown by the significative decrease of the albuminuria in microalbuminuric and macroalbuminuric diabetic patients treated with pharmaceutical compositions administered by oral or intramuscular route containing therapeutically effective amounts of drug.

REFERENCES:
patent: 5252339 (1993-10-01), Cristofori et al.
Chemical Abstracts 120:51646u (1994) Abstracting a 1993 reference.

Affiliated with

Also associated with

Rating

Method of treatment of diabetic nephropathy by means of sulodexi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of diabetic nephropathy by means of sulodexi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of diabetic nephropathy by means of sulodexi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1413030